Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT02671097 Completed - Healthy Volunteers Clinical Trials

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

Start date: February 2016
Phase: Phase 1
Study type: Interventional

Evaluation of the potential perpetrator effect of BAY1841788 (ODM-201) on rosuvastatin pharmacokinetics. PK of BAY1841788 (ODM-201) after single and repeated administration in male and female subjects.

NCT ID: NCT02669121 Completed - Healthy Volunteers Clinical Trials

Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults

Start date: June 14, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of the Norovirus (NoV) GI.1/GII.4 bivalent virus-like particle vaccine against moderate or severe acute gastroenteritis (AGE) due to genotype-specific (GI.1 and GII.4) NoV strains.

NCT ID: NCT02668367 Completed - Healthy Volunteers Clinical Trials

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

Start date: November 2015
Phase: Phase 1
Study type: Interventional

This is a single center, sequential-cohort, double-blind, placebo-controlled, multiple ascending dose (MAD), 7-day treatment period study in healthy subjects.

NCT ID: NCT02665637 Completed - Healthy Volunteers Clinical Trials

Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin

Start date: December 2015
Phase: Phase 1
Study type: Interventional

This is a double-blind, two-arm, parallel-group, single-dose study.

NCT ID: NCT02661178 Completed - Healthy Volunteers Clinical Trials

First in Man Clinical Trial of Emodepside (BAY 44-4400)

Start date: December 2015
Phase: Phase 1
Study type: Interventional

This study will investigate the safety, tolerability, and pharmacokinetics of single ascending doses of emodepside (BAY 44-4400) in healthy male volunteers. This study will also conduct an exploratory investigation of the relative bioavailability of emodepside administered as tablets and determine the effect of food on the pharmacokinetics.

NCT ID: NCT02652936 Completed - Healthy Volunteers Clinical Trials

A Pharmacokinetics Study of AF-130 in Healthy Subjects

Start date: October 2015
Phase: Phase 1
Study type: Interventional

This is a 2-part, single centre, single (Part 1) and multiple (Part 2) dose escalation study in healthy male subjects.

NCT ID: NCT02650895 Completed - Healthy Volunteers Clinical Trials

Safety Study of Efprezimod Alfa (CD24Fc, MK-7110) When Administered Intravenously in Healthy Adult Subjects (MK-7110-001)

Start date: June 2, 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of single ascending intravenous (IV) doses of efprezimod alfa in healthy adult participants.

NCT ID: NCT02647697 Completed - Healthy Volunteers Clinical Trials

Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers

Start date: January 2016
Phase: Phase 1
Study type: Interventional

To evaluate the pharmacokinetics (PK) profile of Radiprodil in suspension form in healthy adult subjects.

NCT ID: NCT02646358 Completed - Healthy Volunteers Clinical Trials

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Start date: January 2016
Phase: Phase 1
Study type: Interventional

This is an open-label study designed to evaluate the effect of renal disease on the pharmacokinetics of vepoloxamer relative to the pharmacokinetics in healthy subjects with normal renal function.

NCT ID: NCT02641353 Completed - Healthy Volunteers Clinical Trials

Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral Suspension

Start date: January 5, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess how much of apremilast is found in the blood unchanged when administered as an oral suspension compared to when it is administered as a tablet formulation. The effect of food on apremilast oral suspension will also be evaluated. In addition, information on the safety and tolerability of apremilast will be obtained.